Sponsors running real-world evidence studies in APAC face a different planning challenge from those running interventional trials. The study design is not the primary source of complexity. The data infrastructure is. So is each market’s regulatory acceptance posture and the site capability to manage observational methodology. Sponsors who treat the APAC region as a single […]